Ellicott City, MD, United States of America

Bira Arya

USPTO Granted Patents = 17 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Frederick, MD (US) (2011)
  • Baltimore, MD (US) (2012 - 2016)
  • Lutherville, MD (US) (2012 - 2018)
  • Ellicott City, MD (US) (2014 - 2018)
  • Elliott City, MD (US) (2019 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
17 patents (USPTO):Explore Patents

Title: Bira Arya: Innovator in Targeted Gene Therapy

Introduction

Bira Arya, an accomplished inventor based in Ellicott City, MD, has significantly contributed to the field of biotechnology with 17 patents to his name. His work focuses on developing innovative compositions and methods for delivering therapeutic agents effectively, aiming to combat various diseases and disorders.

Latest Patents

Among his latest contributions are two noteworthy patents:

1. **Compositions and Methods for Delivering Inhibitory Oligonucleotides**: This invention features compositions that utilize complexes comprising one or more inhibitory nucleic acids and a targeting polypeptide. The targeting polypeptide is derived from a cell surface receptor ligand, which allows for targeted delivery of agents to silence gene expression in cells and potentially treat or prevent a disease.

2. **Plasma Cell Cytokine Vehicle Containing Fusion Proteins for Targeted Introduction of siRNA into Cells and Tissues**: This patent includes a fusion molecule that integrates one or more inhibitory nucleic acids, a targeting polypeptide, and a nucleic acid binding moiety. The innovation focuses on adapting the targeting polypeptide to bind specific RNA structures, thereby enhancing the efficacy of delivering therapeutic oligonucleotides.

Career Highlights

Bira Arya's impressive career includes significant positions at esteemed organizations. He has worked with the United States Department of Health and Human Services and Cyvax, Inc., contributing to groundbreaking research in the areas of gene silencing and targeted therapies.

Collaborations

Throughout his career, Arya has collaborated with other influential figures in the biotech sector, including Larry W. Kwak and Purevdorj B. Olkhanud. These partnerships have not only enriched his research but also facilitated the advancement of innovative solutions in medicine.

Conclusion

Bira Arya stands as a testament to ingenuity and dedication in the realm of biotechnology. His extensive patent portfolio reflects his commitment to advancing science and improving healthcare outcomes through innovative delivery methods for therapeutic agents. As he continues to contribute to the field, the impact of his work will undoubtedly resonate in the scientific community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…